The stereoselective synthesis of 3-substituted and 3,4-disubstituted piperidine and piperidin-2-one derivatives was achieved starting from 2-pyridone. After N-galactosylation and subsequent O-silylation, nucleophilic addition of organometallic reagents proceeded with high regio-and stereoselectivity at 4-position. Substituents at position 3 were stereoselectively introduced by reaction of electrophiles with amide enolates of the N-galactosyl-2-piperidones.
Introduction
In contrast to 2-and 2,6-subsituted piperidine derivates which constitute a whole subclass of piperidine alkaloids [1] , 3-and 3,4-substituted piperidines are only rarely found in Nature. Derivates of 3-hydroxypiperidine, as for example (+)-febrifugine (1) occurring in Chinese medicinal plants [2] , or products of degradation of quinine, as for example, meroquinene or meroquinene aldehyde (2) [3] belong to the few exceptions (Scheme 1). Scheme 1. 3-Substituted piperidine natural products.
The rare occurrence in Nature certainly is the reason that only a few syntheses of 3-alkyl and 3,4-dialkyl-piperidines lacking a 2-substituent have been reported in the literature [4] , although access to these compounds through reduction of the corresponding alkyl-pyridines had been described early [5] . Optically active 3-alkyl and 3,4-dialkyl-piperidines have been obtained by separation of racemic mixtures [5c] in most cases, whereas stereoselective syntheses have rarely been reported. This is surprising since 3,4-di- substituted piperidines have been shown to exhibit attractive biological effects. For example, hexahydroindeno[1,2-c]pyridines 3 have been reported to act as gonadotrophic hormone-releasing hormone agonists/antagonists and integrin antagonists [6] . 4-Aryl-3,4-dimethyl-piperidines 4 obviously exhibit efficient opoid receptor antagonist activity [7] (Scheme 2).
We report here on stereoselective syntheses of 3-alkyl-and 3,4-dialkyl-piperidine derivatives from 2-pyridone according to the strategy of stereoselective desymmetrization induced by N-galactosylation [8] . O-Pivaloylated N-galactosyl-pyridin-2-one 5 [8], after activation with trialkylsilyl trifluoromethanesulfonate to afford the silyloxy-pyridinium intermediate 6, reacted with Grignard compounds or organocuprates to afford 4-subsituted 5,6-dehydro-piperidin-2-ones 7 with complete regio-and excellent stereoselectivity [8] (Scheme 3).
In contrast to N-galactosyl-dehydropiperidin-4-ones obtained either by analogous reactions of N-galactosyl-gamma-pyridone [9] or by tandem-MichaelMannich reactions [10] of N-glycosyl-aldimines with the Danishefsky diene, compounds of type 7 should provide stereoselective access to 3-substituted and 3,4-disubstituted piperidines which do not contain an additional substituent at 2-position.
Results and Discussion
Before the introduction of a 3-substituent is outlined, the removal of the carbohydrate auxiliary should be discussed. As the N-glycosyl amide bond is stable towards acidic conditions, a reduction of the amide carbonyl must be achieved at first. Using N-galactosylpyrid-2-one (5) as the model substrate, catalytic hydrogenation gave N-galactosyl valerolactam (8), while reduction with L-Selectride R in THF at −78 • C regioselectively afforded the 5,6-dehydropiperidin-2-one 9 corresponding to compounds 7 (Scheme 4). All three types of N-galactosyl amides 5, 8 and 9 were converted to the corresponding thioamides 10 -12 using Lawesson's reagent [11] .
The same transformation was also applied to the 4-substituted dehydropiperidin-2-ones 7 and their hydrogenated analogs 13 without affecting their stereogenic centers (Scheme 5) and gave the 4-substituted thioamides 14 and 15.
While deoxygenation of N-galactosyl amides 8, 13 neither with borane nor with superhydride [12] even in the presence of BF 3 etherate [13] was successful, the thioamides 14 were readily desulfurized by hydrogenation in the presence of Raney-nickel with concomitant hydrogenation of the C=C double bond to give the Ngalactosyl piperidines 16 (Scheme 6).
Treatment of the N-galactosyl piperidine 16a with diluted hydrogen chloride in methanol smoothly cleaved the N-glycosidic bond to afford the free piperidine [10] which was converted to the corresponding Obenzyl-urethane 17 for easier characterization.
For the introduction of a 3-substituent, N-galactosyl-valerolactam (8) was deprotonated using lithium hexamethyldisilazane (LiHMDS) in tetrahydrofuran at −78 • C. The alkylation of the amide enolate proceeded slowly. However, the 3-n-butyl-piperidin-2-one 18a was formed with high diastereoselectivity. The 3-methyl derivative 18b was obtained more efficiently, but with lower diastereoselctivity (Scheme 7).
The diastereomers could not be separated by chromatography, and their configuration is not yet clarified. However, in view of the stereochemistry of compounds 7 confirmed by X-ray analysis [8] and the stereocontrol governing their formation, it can be concluded that the enolate is attacked from the (si)-side, and the major diastereomers 18 have (3S)-configuration.
Similar to 8, the 5,6-dehydropiperidin-2-ones 7 and 9 can be alkylated after deprotonation with LiHMDS (Scheme 8).
Scheme 9. Stereoselective aldol reaction at position 3. The results displayed in Table 1 show that high diastereoselectivity is achieved in these 3-alkylations at −78 • C, if no substituent is present in 4-position. The amide enolates of the 4-substituted dehydropiperidinones 7 are also alkylated, but with distinctly lower stereoselectivity. This behavior is in agreement with a stereodifferentiation during the amide enolate alkylation predominantly influenced by the shielding 2-pivaloyloxy substituent of the carbohydrate auxiliary.
Aldehydes as more reactive electrophiles also can be used for the introduction of a 3-substituent. To this end, 4-substituted dehydropiperidinones 7 were converted to their amide enolates at −78 • C. These cyclic (E-)amide enolates only react with aldehydes after their pre-activation with BF 3 etherate [13b] (Scheme 9, Table 2 ).
In this aldol reaction, two new stereogenic centers are formed. As a rule, only two out of four diastereomers could be detected by analytical HPLC. Both of which probably have 3,4-cis configuration, and one of them is generated in a high excess. These results are in agreement with a back-side (si-side) attack of the aldehyde at the amide enolate passing a Zimmerman-Traxler transition state [14] as is displayed in Scheme 10.
According to this interpretation, the major diastereomers of the 3,4-disubsituted piperidin-2-ones 20, which were formed almost exclusively in reactions with benzaldehyde (20a, b) and isobutyraldehyde (20d), should have (3R, αR)-configuration. The lower selectivity found in the reaction with 5-methyl-furfural can be traced back to a coordinating effect of the furan oxygen. The reaction of pivalaldehyde obviously is sterically more hindered, therefore, incomplete and of slightly reduced selectivity, whereas acrolein is very reactive and logically less selective. It should also be noticed that ketones, as for example acetophenone, did not undergo this aldol reaction. These findings suit with the suggested Zimmerman-Traxler mechanism (Scheme 10). The intramolecular version of the enantioselective aldol reaction should provide access to 3,4-annulated piperidine frameworks as is present, for example, in the monoterpene alkaloid α-skytanthin [15] . As a suitable starting material, 4-butenyl-5,6-dehydropiperidin-2-one 7f [8] was selectively reduced at the enamine double bond by protonation with conc. hydrochloric acid and subsequent treatment with sodium cyanoborohydride. The quantitatively obtained N-galactosyl-valerolactam 21 was subjected to osmate-promoted dihydroxylation to give 22, and its subsequent diol-cleavage using lead tetraacetate [16] led to valerolactam 23 containing an aldehyde function in the side chain (Scheme 11).
It is noteworthy, that the LiHMDS-promoted deprotonation of 23 did not induce the cyclizing aldol reaction. Obviously, the lithium ion-coordinated Zimmerman-Traxler transition state is too much strained and the lithium-coordinated amide enolate too weakly nucleophilic. Only deprotonation with potassium hexamethyldisilazane (KHMDS) producing the more nucleophilic potassium enolate resulted in the desired aldol reaction. Again, of the four possible diastereomers only the two cis-diastereomers have been formed. However, due to the weaker coordinating effect of the potassium ion, the stereodifferentiation of the prochiral aldehyde only amounts to 4 : 1 and cannot Scheme 11. 3,4-Annulated piperidinones.
be predicted by a six-membered ring transition state. The configuration of the major diastereomer could not be confirmed so far, because the compound did not crystallize, and overlap of the crucial signals in the 1 H NMR spectrum rendered the interpretation difficult.
Conclusion
Although their configurations have not yet been confirmed by X-ray analyses, 3-substituted and 3,4-disubstituted piperidine derivatives have been obtained stereoselectively starting from 2-pyridone via N-galactosylation. The N-galactosyl auxiliary in N-galactosyl valerolactam (9) , N-galactosyl-5,6-dehydropiperidin-2-ones 10 and their 4-substituted derivatives 7 as well as in their amide enolates obviously causes an efficient stereodifferentiation in substitution reactions at position 3 of the piperidinone ring. This holds for alkylation processes as well as for aldol reactions. In some cases of the aldol reactions, only one out of four diastereomers was obtained. The observed effects of a substituent at 4-position in substitution reactions at 3-position support the hypothesis that amide enolates of N-D-galactosyl-piperidin-2-ones are preferably attacked from the si-side due to the shielding effect of the large 2-pivaloyloxy substituent of the carbohydrate auxiliary. Model reactions have shown that the N-galactosyl auxiliary can be removed from the chiral piperidine products via conversion of the piperidinones into the corresponding thioamides, their reductive desulfurization and subsequent acidolysis of the N-glycosidic bond.
Experimental Section

General instrumentation
Reagents and solvents were distilled before use: Tetrahydrofuran, dioxane, and Et 2 O were distilled from potassiumbenzophenone ketyl. CH 2 Cl 2 was distilled from CaH 2 . Light petroleum refers to bp 60 -80 • C. All reactions and distillations were carried out in flame-dried glassware under argon atmosphere.
Reversed-phase analytical HPLC was carried out using a Knauer system (Knauer MaxiStar K1000 pump and DAD2062 for diode array detection), acetonitrile-water, flow rate: 1 cm 3 min −1 . Column: A: Luna C8, 5 µ, 250 × 4 mm, Phenomenex; for chiral analytical HPLC: "Chiralpak AD, Daicel Chemical Industries and n-hexane-iso-propanol as eluents, flow rate: 1 cm 3 min −1 . Thin-layer chromatography (TLC) was performed on Merck silica gel 60 F254 , flash chromatography on silica (32 -63 µm, ICN Biochemicals). FD mass spectra were measured on a Finnigan MAT 95 spectrometer, ESI mass spectra on a ThermoQuest Navigator instrument. High-resolution ESI mass spectra were recorded on a Q-TOF Ultima 3 instrument (Waters, NaI-CsI as the internal reference). Melting points were taken on a Büchi Dr. Tottoli apparatus and are uncorrected. 1 H and 13 C NMR spectra were recorded on a Bruker AC-300 or a Bruker AM-400 NMR instrument. Chemical shifts δ are given in ppm.
Optical rotation values were measured with a Perkin-Elmer 241 polarimeter.
The synthesis of the 4-substituted 5,6-dehydropiperidin-2-ones 7 has been described in reference [8] .
N-Galactosyl-piperidin-2-ones 8 and 13 through hydrogenation -General procedure
To the solution of N-galactosyl-2-pyridone (5) or N-galactosyl-5,6-dehydropiperidin-2-one (7) [8] in dry methanol palladium on charcoal (10 %, 15 mg) was added. The mixture was stirred under hydrogen atmosphere at r. t. until monitoring by TLC showed complete conversion. Subsequently, the hydrogen was substituted by argon, the catalyst was filtered off, and the solvent was evaporated in vacuo. The remaining crude product was purified by flash chromatography.
N-(2,3,4,6-Tetra-O-pivaloyl-β -D-galactopyranosyl)piperidin-2-one (8)
Educt N- (2,3,4,6- 
(4S)-4-Ethyl-N-(2,3,4,6-tetra-O-pivaloyl-β -D-galactopyranosyl)piperidin-2-one (13a)
Educt (4R)-4-ethyl-3,4-dihydro-N-(2,3,4,6-tetra-O-piva- loyl-β -D-galactopyranosyl)pyridine-2(1H)-
(4S)-4-Propyl-N-(2,3,4,6-tetra-O-pivaloyl-β -D-galactopyranosyl)piperidin-2-one (13b)
Educt (4R)-3,4-dihydro-4-propyl-N-(2,3,4,6-tetra-O-pi- valoyl-β -D-galactopyranosyl)pyridine-2(1H)-one [8] (7b):0.45 g (0.7 mmol) 7b; reaction time: 24 h. Yield: 0.331(4S)-4-Isopropyl-N-(2,3,4,6-tetra-O-pivaloyl-β -D-galacto- pyranosyl)piperidin-2-one (13c) Educt (4R)−3,4-dihydro-4-isopropyl-N-(2,3,4,6-tetra-O- pivaloyl-β -D-galactopyranosyl)pyridine-2(1H)-
(4S)-4-(4-Fluorophenyl)-N-(2,3,4,6-tetra-O-pivaloyl-β -Dgalactopyranosyl)piperidin-2-one (13d)
Educt (4S)−3,4-dihydro-4-(4-fluorophenyl)-N-(2,3,4,6- tetra-O-pivaloyl-β -D-galactopyranosyl)pyridine-2(1H)-
3,4-Dihydro-N-(2,3,4,6-tetra-O-pivaloyl-β -D-galactopyranosyl)pyridine-2(1H)-one (9)
To a solution of N- (2,3,4,6- (5) (5 g 
Synthesis of pyridine-2-and hydropyridin-2-thiones -General procedure
To the solution of the corresponding N-galactosyl-dehydropiperidin-2-one or N-galactosyl-pyrid-2-one in dry toluene, Lawesson's reagent [9] was added. The solution was stirred and heated under reflux. After completion of the conversion (TLC monitoring) and cooling to r. t., ethyl acetate (mL) and water (50 mL) were added. The organic solution was dried with MgSO 4 , and the solvent was evaporated in vacuo. The remaining residue was purified by flash chromatography.
N-(2,3,4,6-Tetra-O-pivaloyl-β -D-galactopyranosyl)pyridine-2(1H)-thione (10)
3,4-Dihydro-N-(2,3,4,6-tetra-O-pivaloyl-β -D-galactopyranosyl)pyridine-2(1H)-thione (12)
Educt
(4R)-4-Ethyl-3,4-dihydro-N-(2,3,4,6-tetra-O-pivaloyl-β -Dgalactopyranosyl)pyridine-2(1H)-thione (14a)
Educt ( (4R)-3,4-Dihydro-4-propyl-N-(2,3,4 (4R)-3,4-Dihydro-4-(4-fluoro-phenyl)-N-(2,3,4 
,6-tetra-O-pivaloyl-β -Dgalactopyranosyl)pyridine-2(1H)-thione (14b)
Educt (4R)-3,4-dihydro-4-propyl-N-(2,3,4,6-tetra-O-pi- valoyl-β -D-galactopyranosyl)pyridine-2(1H)-
(4S)-4-Isopropyl-N-(2,3,4,6-tetra-O-pivaloyl-β -D-galactopyranosyl)-5,6-dehydro-piperidin-2-thione (14c)
Educt (4S)-3,4-dihydro-4-isopropyl-N-(2,3,4,6-tetra- O-pivaloyl-β -D-galactopyranosyl)pyridine-2(1H)-
,6-tetra-O-pivaloyl-β -D-galactopyranosyl)pyridine-2(1H)-thione (14d)
Educt ( 
(4S)-4-(4-Fluorophenyl)-N-(2,3,4,6-tetra-O-pivaloyl-β -Dgalactopyranosyl)piperidin-2-thione (15)
Reductive Sulfurization -General procedure
To a solution of the thiolactam in dry isopropanol freshly prepared, neutrally washed Raney nickel was added. The suspension was stirred under hydrogen atmosphere at 70 • C and the conversion montored by TLC. After completion of the reaction, the catalyst was filterred off through Celite and thouroughly washed with isopropanol. The combined filtrates were evaporated to dryness in vacuo, and the remaining crude product was purified by flash chromatography.
4-Ethyl-N-(2,3,4,6-tetra-O-pivaloyl-β -D-galactopyranosyl)-piperidine (16a)
4-Propyl-N-(2,3,4,6-tetra-O-pivaloyl-β -D-galactopyranosyl)piperidine (16b)
Educt ( C-5, C-4, C-3, C-2), 94.40 (C-1), 176.77, 176 .88, 177.22, 177.86 (PivC=O).
Detachment of the carbohydrate auxiliary from piperidinesGeneral procedure
The N-galactosyl-piperidine (0.5 mmol) dissolved in methanol (15 mL) and 1N solution of HCl in methanol (6 mL) was stirred for 24 h. Subsequently, HCl and the solvent were removed in vacuo, and the remaining crude piperidinium chloride was stirred in water (50 mL) and diethyl ether (50 mL) for 5 min. The separated water solution was extracted twice with diethyl ether (50 mL). The combined ether solutions were washed with water (50 mL). The ether solution contained the tetra-O-pivaloyl-galactose. The combined water solutions were evaporated to dryness to give the piperidine hydrochloride.
N-(Benzyloxycarbonyl)-4-ethyl-piperidine (17)
The hydrochloride of 4-ethyl-piperidine was obtained from 4-ethyl-N-(2,3,4,6-tetra-O-pivaloyl-β -D-galactopyranosyl)piperidine (16a) (220 mg, 0.36 mmol) in methanol (10 mL) and 4 mL of 1 N methanolic HCl (reaction time 24 h). Yield: 37 mg (70 %), colorless amorphous solid. This hydrochloride was dissolved in 2 mL of water. After addition 2 mL of sat. Na 2 CO 3 solution, the mixture was stirred for 1 h at r. t. Subsequently, benzyl chloroformate (53 µL, 0.38 mmol, 1.5 equiv.) was added and the mixture stirred for 2 h. The solution was extracted three times with diethyl ether (30 mL), the combined organic solutions were dried with MgSO 4 , and the solvent was evaporated in vacuo. Purification of the crude product was performed by flash chromatography.
Yield: 52 mg (84 %) 17, colorless oil, R f = 0.14 (cyclohexane-ethyl acetate 4 : 1 
C-3 Alkylation of N-galactosyl piperidin-2-ones -General procedure
To the solution of the N-galactopyranosyl-piperidin-2-one in THF at −78 • C, lithium hexamethyldisilazane (LiHMDS, 1 M solution in THF) was added. After 1 h stirring at this temperature, the alkyl iodide was added and the stirring continued for 15 h at the given temperature. The reaction was terminated by addition of sat. NH 4 Cl solution (20 mL) at the low temperature. After warming to r. t., the solution was extracted three times with diethyl ether (100 mL). The combined organic solutions were dried with MgSO 4 , the solvent was evaporated in vacuo, and the residue was purified by flash chromatography.
3-Butyl-1-(2,3,4,6-tetra-O-pivaloyl-β -D-galactopyranosyl)-piperidin-2-one (18a)
The reaction was carried out at −10 • C starting from piperidinone 8 (0. 
3-Methyl-N-(2,3,4,6-tetra-O-pivaloyl-β -D-galactopyranosyl)piperidin-2-one (18b)
The reaction was carried out at −78 • C starting from piperidinone 8 (0.2 g, 0.335 mmol) dissolved in 3 mL of dry THF, treated with 0.57 mL (0.57 mmol, 1.7 equiv.) of LiHMDS solution, and using 63 µL 
3,4-Dihydro-3-methyl-N-(2,3,4,6-tetra-O-pivaloyl-β -Dgalactopyranosyl)pyridine-2(1H)-one (19a)
The reaction was carried out at −78 • C starting from 5,6-dehydropiperidinone 9 (0.2 g, 0.335 mmol) dissolved in 3 mL of dry THF, treated with 0.57 mL (0.57 mmol, 1.7 equiv.) of LiHMDS solution, and using 63 µL (1.0 mmol, 3 equiv.) of methyl iodide. Purification was achieved by flash chromatography (20 × 1 cm, cyclohexane-ethyl ac- 
3-Butyl-3,4-dihydro-N-(2,3,4,6-tetra-O-pivaloyl-β -Dgalactopyranosyl)pyridine-2(1H)-one (19b)
The reaction was carried out at −78 • C starting from 5,6-dehydropiperidinone 9 (0.2 g, 0.335 mmol) dissolved in 3 mL of dry THF, treated with 0.57 mL (0.57 mmol, 1.7 equiv.) of LiHMDS solution, and using 0.114 mL (4R)-3,4-Dihydro-3-methyl-4-propyl-N-(2,3,4,6 
-tetra-O-pivaloyl-β -D-galactopyranosyl)pyridine-2(1H)-one (19c)
The reaction was carried out at −78 • C starting from 4-propyl-5,6-dehydropiperidin-2-one (7b) (0.1 g, 0.157 mmol) dissolved in 3 mL of dry THF, treated with 0.27 mL (0.27 mmol, 1.7 equiv.) of LiHMDS solution, and using 0.03 mL (0.47 mmol, 3 equiv.) of methyl iodide. Purification was performed by flash chromatography (20 × 1 cm, light petroleum-ethyl acetate 8 : 1 
Aldol addition reaction at N-galactosylpiperidin-2-onesGeneral procedure
To the solution of the N-galactosyl-piperidin-2-one (7) in dry THF at −78 • C, 1.0 M LiHMDS solution was added. After stirring at this temperature for 15 min, a solution of the aldedyde and BF 3 · OEt 2 , stirred for some time (see: individual compounds) was added. The mixture was stirred at r. t. for 12 h. Subsequently, sat. NH 4 Cl solution was added and the solution extracted three times with diethyl ether. The combined organic solutions were dried with MgSO 4 and evaporated in vacuo. Purification was carried out by flash chromatography using cyclohexane-ethyl acetate containing 1 % (v/v) of NEt 3 as the eluent.
